Type 2 diabetes mellitus
Pro Research Analysisby 
Searched over 200M research papers
Overview of Type 2 Diabetes Mellitus: Definition and Prevalence
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder marked by high blood sugar (hyperglycemia) and is closely linked to the global rise in obesity. It accounts for about 90–95% of all diabetes cases and is a major contributor to morbidity and mortality worldwide due to its complications and comorbidities DeFronzo2015Syamsurizal2018Chaudhury2017.
Pathophysiology and Risk Factors of Type 2 Diabetes
Insulin Resistance and Beta-Cell Dysfunction
The core defects in T2DM are insulin resistance—where the body’s tissues do not respond properly to insulin—and impaired insulin secretion from pancreatic beta cells. These defects disrupt glucose homeostasis and are influenced by both genetic and environmental factors DeFronzo2015Galicia-Garcia2020Xourafa2023+1 MORE. At least six other pathophysiological abnormalities, including mitochondrial dysfunction, local inflammation, and altered metabolic signaling, also contribute to the disease DeFronzo2015Xourafa2023Pinti2019.
Genetic and Environmental Contributors
T2DM is inherited in a polygenic manner, with several genes such as TCF7L2, KCNJ11, and FTO implicated in its development. Environmental risk factors include obesity, unhealthy diet, physical inactivity, smoking, hypertension, stress, and a family history of diabetes DeFronzo2015Syamsurizal2018Xourafa2023.
Inter-Organ Crosstalk and Mitochondrial Dysfunction
The disease involves complex interactions between organs like adipose tissue, skeletal muscle, liver, pancreas, and intestine. Disrupted communication between these organs, often mediated by metabolites, peptides, and microRNAs, plays a key role in disease progression. Mitochondrial dysfunction across these organs further impairs energy metabolism and insulin action Xourafa2023Pinti2019.
Complications of Type 2 Diabetes Mellitus
Microvascular and Macrovascular Complications
T2DM increases the risk of both microvascular complications (retinopathy, nephropathy, neuropathy) and macrovascular complications (cardiovascular disease). These complications are driven by chronic hyperglycemia and insulin resistance, and are major causes of blindness, kidney failure, and cardiovascular events in affected individuals DeFronzo20158Mansour2023.
Genetic Susceptibility to Complications
Recent studies have identified specific genetic loci associated with different T2DM complications, suggesting that genetic background can influence the risk and type of complications experienced by patients .
Diagnosis and Monitoring
Regular screening for microvascular complications is essential to prevent or slow their progression. Key biochemical markers for monitoring include fasting blood glucose, lipid profile, glycated hemoglobin (HbA1c), and urine albumin-to-creatinine ratio .
Treatment and Management Strategies
Multi-Target and Combination Therapies
Due to the multifactorial nature of T2DM, effective management often requires a combination of antidiabetic agents targeting different aspects of the disease, such as insulin sensitivity, insulin secretion, and glucose absorption. Multi-target drugs and phytocomplexes are being explored to address both blood glucose control and comorbidities DeFronzo2015Artasensi2020Chaudhury2017.
Lifestyle Interventions
Carbohydrate-restricted diets and increased physical activity have been shown to improve glycemic control and reduce insulin levels, supporting their use as foundational treatments for T2DM .
Novel Therapeutic Approaches
There is ongoing research into new medications that enhance insulin sensitivity, protect pancreatic beta cells, and prevent or reverse complications. Mitochondria-targeted therapies are also being investigated to restore cellular energy balance and improve metabolic health in T2DM DeFronzo2015Pinti2019.
Conclusion
Type 2 diabetes mellitus is a complex, multifactorial disease driven by genetic, environmental, and metabolic factors. It leads to significant health complications if not managed effectively. Early detection, regular monitoring, lifestyle changes, and multi-targeted pharmacological interventions are key to improving outcomes and quality of life for individuals with T2DM DeFronzo2015Galicia-Garcia2020Artasensi2020+7 MORE.
Sources and full results
Most relevant research papers on this topic